Radiopharm Theranostics Limited Sponsored ADR had a revenue of ― in the quarter ending ―, with ―. This bring the company's revenue in the last twelve months to ―, Decreased ―. In the fiscal year ending Jun 30, 2024, Radiopharm Theranostics Limited Sponsored ADR had annual revenue of 299.23K with 2.35% growth.